Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Other financing activities (2020 - 2025)

Zai Lab (ZLAB) has disclosed Other financing activities for 4 consecutive years, with -$660000.0 as the latest value for Q3 2025.

  • Quarterly Other financing activities rose 5.71% to -$660000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $194000.0 through Dec 2025, down 72.29% year-over-year, with the annual reading at $194000.0 for FY2025, 72.29% down from the prior year.
  • Other financing activities hit -$660000.0 in Q3 2025 for Zai Lab, down from $854000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $973000.0 in Q1 2021 to a low of -$700000.0 in Q3 2024.
  • Historically, Other financing activities has averaged $303444.4 across 3 years, with a median of $513000.0 in 2021.
  • Biggest YoY gain for Other financing activities was 2592.31% in 2021; the steepest drop was 99.98% in 2021.
  • Year by year, Other financing activities stood at $1000.0 in 2021, then surged by 69900.0% to $700000.0 in 2024, then crashed by 194.29% to -$660000.0 in 2025.
  • Business Quant data shows Other financing activities for ZLAB at -$660000.0 in Q3 2025, $854000.0 in Q2 2025, and $700000.0 in Q4 2024.